Literature DB >> 24611443

Relationship of PTTG expression with tumor invasiveness and microvessel density of pituitary adenomas: a meta-analysis.

Yan Li1, Li-Ping Zhou, Ping Ma, Cheng-Guang Sui, Fan-Dong Meng, Xin Tian, Li-Ye Fu, You-Hong Jiang.   

Abstract

AIMS: Many existing studies have demonstrated that pituitary tumor transforming gene (PTTG) expression may contribute to the development of pituitary adenomas (PAs), but individually published studies showed inconclusive results. This meta-analysis aimed to derive a more precise estimation of the relationships of PTTG expression with tumor invasiveness and microvessel density of pituitary adenomas.
METHODS: We searched CISCOM, CINAHL, Web of Science, PubMed, Google Scholar, EBSCO, Cochrane Library, and CBM databases from inception through September 1st, 2013. Meta-analysis was performed using the STATA 12.0 software. The crude odds ratio (OR) with 95% confidence interval (CI) was calculated.
RESULTS: Fifteen clinical cohort studies were included with a total of 752 pituitary adenoma patients. The meta-analysis results revealed that patients with invasive pituitary adenomas had higher positive expression of PTTG than those of noninvasive patients (OR=6.68, 95% CI=3.72-11.99, p<0.001). We also found a significant difference in the microvessel density between invasive and noninvasive patients (OR=1.81, 95% CI=0.39-3.23, p<0.001). No publication bias was detected in this meta-analysis (all p>0.05).
CONCLUSION: The present meta-analysis suggests that PTTG expression may be associated with tumor invasiveness and microvessel density of pituitary adenomas. Thus, detection of PTTG expression may be useful for the prediction of malignancy degree in pituitary adenomas.

Entities:  

Mesh:

Year:  2014        PMID: 24611443     DOI: 10.1089/gtmb.2013.0447

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  5 in total

1.  PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.

Authors:  Xiu Wang; Wanxing Duan; Xuqi Li; Jiangbo Liu; Donghong Li; Lianhong Ye; Lu Qian; Aijun Yang; Qinhong Xu; Han Liu; Qiaoshan Fu; Erxi Wu; Qingyong Ma; Xin Shen
Journal:  Oncotarget       Date:  2015-12-01

2.  Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas.

Authors:  R K Foltran; P V G H Amorim; F H Duarte; I P P Grande; A C T B Freire; F P Frassetto; J B Dettoni; V A Alves; I Castro; E B Trarbach; M D Bronstein; R S Jallad
Journal:  Braz J Med Biol Res       Date:  2018-06-25       Impact factor: 2.590

Review 3.  Molecular Network Basis of Invasive Pituitary Adenoma: A Review.

Authors:  Qi Yang; Xuejun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-24       Impact factor: 5.555

4.  Association of PTTG1 expression with invasiveness of non-functioning pituitary adenomas.

Authors:  Su Jung Kum; Hye Won Lee; Soon Gu Kim; Hyungsik Park; Ilseon Hwang; Sang Pyo Kim
Journal:  J Pathol Transl Med       Date:  2021-10-15

Review 5.  Pituitary Apoplexy: Risk Factors and Underlying Molecular Mechanisms.

Authors:  Betina Biagetti; Rafael Simò
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.